1-3 of 3
Arianna Ghirardi
Close
Sort by
Journal Articles

Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study

Clinical Trials & Observations
Paola Guglielmelli, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Chiara Maccari, Barbara Mora, Elisa Rumi, Ana Triguero, Maria Chiara Finazzi, Helna Pettersson, Chiara Paoli, Francesco Mannelli, Daniele Vanni, Alessandro Rambaldi, Francesco Passamonti, Alberto Alvarez-Larràn, Bjorn Andreasson, Alessandro M. Vannucchi, Tiziano Barbui
Journal: Blood Advances
Blood Adv (2022) 6 (2): 373–375.
https://doi.org/10.1182/bloodadvances.2021006006
Published: 2022
Includes: Supplemental data
Journal Articles

Ruxolitinib for the prevention of thrombosis in polycythemia vera: a systematic review and meta-analysis

Arianna Masciulli, Alberto Ferrari, Alessandra Carobbio, Arianna Ghirardi, Tiziano Barbui
Journal: Blood Advances
Blood Adv (2020) 4 (2): 380–386.
https://doi.org/10.1182/bloodadvances.2019001158
Published: 2020
Includes: Supplemental data
Journal Articles

Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis

Clinical Trials & Observations
Alessandra Carobbio, Alberto Ferrari, Arianna Masciulli, Arianna Ghirardi, Giovanni Barosi, Tiziano Barbui
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1729–1737.
https://doi.org/10.1182/bloodadvances.2019000211
Published: 2019
Includes: Supplemental data